[Therapeutic effect of lisuride maleate on post-stroke depression]. 1994

H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
First Department of Medicine, Osaka University Medical School.

Twenty post-stroke depressive patients who obtained more than 11 points on Self-Rating Questionnaire for Depression, were treated with 0.075 mg/day lisuride maleate for 12 weeks. The drug effect on depression was evaluated quantitatively by the Hamilton Rating Scale for Depression. The relationships between brain CT or MRI and SRQ-D score were investigated in 24 subjects. More than 80% of post-stroke depressive patients improved after lisuride maleate treatment for 8 or 12 weeks. In particular, depressed mood, hypobulia, sleep disturbance, anxiety, etc. were significantly improved compared to the baseline condition. As for the relationships with CT and/or MRI findings, the group with moderate to severe brain atrophy had a significantly higher grade of depressive state than those without.

UI MeSH Term Description Entries
D008090 Lisuride An ergot derivative that acts as an agonist at dopamine D2 receptors (DOPAMINE AGONISTS). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (SEROTONIN RECEPTOR AGONISTS). Lysuride Hydrogen Maleate,Methylergol Carbamide,Arolac,Cuvalit,Dopergin,Dopergine,Lisuride Hydrochloride,Lisuride Maleate,Lisuride Maleate (1:1),Lisuride Maleate, (8beta)-Isomer,Lisuride Mesylate,Lisuride Phosphate (1:1),Lisuride, (8alpha)-(+-)-Isomer,Lysenyl,Lysurid,Revanil,Carbamide, Methylergol,Hydrochloride, Lisuride,Hydrogen Maleate, Lysuride,Maleate, Lisuride,Mesylate, Lisuride
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
January 1981, European journal of clinical pharmacology,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
May 2023, World journal of psychiatry,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
February 2007, Zhen ci yan jiu = Acupuncture research,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
April 2011, Zhongguo zhen jiu = Chinese acupuncture & moxibustion,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
March 1976, Endocrinology,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
May 1978, Headache,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
July 1979, Clinical endocrinology,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
December 1996, Ginecologia y obstetricia de Mexico,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
September 2019, Neuropharmacology,
H Hougaku, and M Matsumoto, and R Hata, and N Handa, and M Imaizumi, and Y Sugitani, and S Yoneda, and H Etani, and K Sueyoshi, and M Kusunoki
January 1986, European neurology,
Copied contents to your clipboard!